March 31, 2016
Nexstim Plc provides key update on Phase III NICHE stroke therapy trial
Media
March 24, 2016
Strongbridge Biopharma plc Reports Full-Year 2015 Financial Results
March 21, 2016
Onxeo Announces Establishment of U.S. Subsidiary
March 18, 2016
AstraZeneca acquires all rights to Orexo´s OX-CLI project
March 10, 2016
TARGOVAX ANNOUNCES ENCOURAGING INTERIM RESULTS WITH RAS SPECIFIC PEPTIDE VACCINE IN RESECTED PANCREATIC CANCER
March 09, 2016
Cancer Company Aprea Closes EUR 46 Million (~USD 51 Million) Series B Financing
March 07, 2016
Strongbridge Biopharma plc Provides Update on Corporate Progress
March 02, 2016
2015 annual results
March 02, 2016
INTERIM REPORT FOURTH QUARTER 2015
March 01, 2016
NANO: LATE-BREAKING ABSTRACT ON BETALUTIN® PHASE 1/2 STUDY ACCEPTED FOR PRESENTATION AT AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING 2016
